The role of duloxetine in the treatment of anxiety disorders

Anxiety disorders (ADs) are the most common type of psychiatric disorders, with a mean incidence of 18.1% and a lifetime prevalence of 28.8%. Pharmacologic options studied for treating ADs may include benzodiazepines, tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRIs),...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: De Berardis, Domenico, Serroni, Nicola, Carano, Alessandro, Scali, Marco, Valchera, Alessandro, Campanella, Daniela, D’Albenzio, Alessandro, Di Giuseppe, Berardo, Moschetta, Francesco Saverio, Salerno, Rosa Maria, Ferro, Filippo Maria
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2008
Sujets:
Expert Opinion
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626928/
https://ncbi.nlm.nih.gov/pubmed/19183783
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires